drugset

drugset / Trial / NCT03834766

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

NCT03834766 ↗

Phase 3 Completed 130 enrolled Tris Pharma, Inc. Premier Research · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy of AMPH ER TAB compared to placebo in adult patients with ADHD aged 18 to 60 years.

Timeline

Start: 2019-02-06
Primary completion: 2019-10-19
Completion: 2019-10-19

Publications

Cutler AJ, Childress AC, Pardo A, Duhoux S, Gomeni R, Rafla E, King TR, Kando JC. Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of Amphetamine Extended-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder. J Clin Psychiatry. 2022 Jul 20;83(5):22m14438. doi: 10.4088/JCP.22m14438.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Amphetamine	Unknown	20 mg	Oral

Indications